Scientists hunt for clues to stop brain Cancer's return
NCT ID NCT07173829
First seen Oct 01, 2025 · Last updated Jun 23, 2026 · Updated 48 times
Summary
This study will collect blood and tumor samples from 45 adults with glioblastoma, a serious brain cancer, to understand why it often returns after treatment. Researchers will look at molecular, immune, and metabolic changes in the samples. The goal is to find new ways to target the cancer and improve therapies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could reveal new targets for therapies that slow or prevent glioblastoma recurrence.
What could go wrong
This is an early observational study with only 45 participants, so findings may not apply to all patients or lead directly to new treatments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.